CapsulesMRP Under Process
Official PMBI MRP is being updated for catalog code 2152.
Locate Jan Aushadhi KendraClinical Overview
Beclomethasone Dipropionate Inhalation (100mcg, 200mcg Inhaler, 100mcg Rotacaps) is a halogenated synthetic corticosteroid prodrug on the WHO Model List of Essential Medicines. In lung tissue, esterases rapidly convert it to active beclomethasone-17-monopropionate (17-BMP), which possesses 30-fold higher affinity for glucocorticoid receptors, profoundly suppressing bronchial mucosal inflammation. Indicated for maintenance treatment of persistent bronchial asthma and chronic bronchitis.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Inhale 100 mcg to 400 mcg twice daily (morning and evening) via MDI or DPI device. Rinse mouth thoroughly with water and spit out after use.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Oral candidiasis, hoarseness, throat irritation, cough. Rare/Severe: Paradoxical bronchospasm and systemic corticosteroid effects with prolonged high doses.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Rinse mouth with water and spit out after use. Not for immediate relief of acute bronchospasm.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, pulmonological diagnosis, or respiratory management recommendations. Inhalation therapies and allergy medications should be used strictly under the guidance of a qualified pulmonologist or registered medical practitioner.
Beclomethasone Dipropionate 0.025%, Clotrimazole 1% and Gentamicin Sulphate 0.1% Cream
Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.
Beclomethasone 0.025% and Neomycin 0.5% Cream
Beclomethasone 0.025% and Neomycin 0.5% Cream is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.
Clotrimazole 1% and Beclometasone Dipropionate 0.025% Lotion
Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.
Clotrimazole 1% and Beclomethasone Dipropionate 0.025% Cream
Clotrimazole (1% w/w cream, lotion, or dusting powder) is a versatile broad-spectrum imidazole antifungal on the WHO Model List of Essential Medicines. It inhibits fungal cytochrome P450 14-alpha-demethylase, depleting ergosterol and increasing fungal cell permeability. Dusting powder formulation absorbs excess moisture in intertriginous skin folds, preventing fungal maceration. Indicated for tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis, and prevention of recurrence in sweaty body folds.